Search Results 1821-1830 of 16332 for Chronic Lymphocytic Leukemia
The purpose of this trial is to determine whether aggressive medication treatment to modify risk factors in women with coronary arteries showing no severe ...
Hemoglobin < 10 g/dL. Confirmed diagnosis of myelofibrosis (primary ... chronic myelogenous leukemia [CML], polycythemia vera [PV], myelodysplastic ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The investigators' proposed study is a randomized controlled trial that will prospectively examine the effect of a multicomponent ...
Adults ≥ 40 years without a diagnosis of multiple myeloma · Self-reported east African ancestry (including individuals of mixed east African descent) · Willing ...
Please confirm when you call to request an appointment. Edit search filters. View all conditions. Acute kidney injury · Chronic kidney disease · Diabetes ...
In severe COPD patients, sputum eosinophils levels are elevated similar as those seen in severe asthmatics. It is hypothesized that the reduction of eosinophils ...
Long-term care facilities are taking steps to prepare and respond to the COVID-19 (coronavirus) pandemic. With guidance from the Centers for Disease Control ...
... diagnosis, clinical practice, research and education. Khashayarsha Khazaie, Ph.D., and Amir A. Sadighi Akha, M.D., D.Phil., serve as the director and ...
... severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Participation eligibility. Participant eligibility ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.